Open Access

Hyperinsulinemia may have a protective role in the early stages of atherosclerosis in rabbit model of hypercholesterolemia

  • Shaghayegh Haghjooy Javanmard1,
  • Mehdi Nematbakhsh2,
  • Azam Feghhi1 and
  • Nasim Dana1Email author
Journal of Diabetes & Metabolic Disorders201211:5

DOI: 10.1186/2251-6581-11-5

Received: 18 July 2012

Accepted: 2 August 2012

Published: 2 August 2012

Abstract

Background

Hypercholesterolemia causes inflammation and insulin resistance in the vasculature. Previous data suggest that vascular endothelium is a physiological target of insulin. Dyslipidemia and atherosclerosis are disorders with endothelial dysfunction that are associated with an increased production of superoxide anion, and early deficit of nitric oxide (NO) production. We examined alteration of plasma levels of insulin, C-reactive protein (CRP) and total NO metabolites (NOx), as well as fatty streak formation in the rabbit model of hypercholesterolemia.

Methods

White male rabbits were fed either a high-cholesterol diet (HC; 1% cholesterol, n = 6) or control diet (c, n = 6) for one month. The serum levels of Cholesterol, LDL, HDL, NOx, insulin and CRP were measured before and after study. By the end of study, rabbits' aorta was explored for fatty streak formation.

Results

The cholesterol-rich diet induced a significant increase in total cholesterol, LDL, and HDL as well as fatty streak lesions in HC group while there were no significant changes of these parameters in control group (p <0.05). There was significant difference in plasma levels of CRP, insulin and total NO metabolite between two groups of experiment. Negative significant correlation of CRP and insulin also was observed in HC rabbits (r = −0.99, p <0.05).

Conclusion

Parallel NOx and insulin increment and negative correlation of CRP and insulin in HC rabbits may be suggestive a protective role of hyperinsulinemia in early atherosclerosis.

Keywords

Inflammation Hypercholesterolemia Insulin C-reactive protein Nitric oxide

Introduction

Considerable data suggest vascular endothelium as a physiological target of insulin [1, 2]. In addition to the eminent metabolic effects, insulin has important vascular actions. Insulin stimulate production of nitric oxide (NO) from endothelium by phosphatidyl inositol 3-kinase (PI3K)-dependent signaling pathways [3]. Pathophysiologic conditions such as hyperlipidemia, and inflammation selectively impair PI3K dependent insulin signaling pathways, creating reciprocal relationships between insulin resistance and endothelial dysfunction (ED)[3], and ED is associated with deficit of NO production [4].

It is reported that NO has direct effects on the progression of atherosclerosis [5], but chronic inhibition of NO in the presence of a high-cholesterol diet has been shown to induce development of atherosclerosis [6]. Furthermore, reducing endothelial NO levels is a known mechanism for inducing insulin resistance [7]. This fact is tempting to hypothesize a potential link between insulin resistance and atherosclerosis. It has been suggested that reduced bioavailability of NO by insulin resistance may be an additional pathogenic factor in atherosclerosis [7, 8]. The exact molecular relationship between insulin, ED and atherosclerosis is presently unknown [9]. In order to elucidate this relationship, studying the early variation of insulin during induction of hypercholesterolemia may help cognizance the pathogenesis of atherosclerosis.

Therefore in this study we examined plasma levels of insulin, C-reactive protein (CRP) and total NO metabolites (NOx), as well as fatty streak formation in the rabbit model of hypercholesterolemia.

Methods

Animals and experimental design

The study was reviewed and approved by the Ethics Committee of Isfahan University of Medical Sciences. Twelve white male rabbits weighing between 1.9 ± 0.1 kg were obtained from the Pasteur Institute of Iran. After 1-week acclimatization period and overnight fasting, blood samples were taken as pre-experimental sampling. Blood samples were collected in heparinated tubes, centrifuged (10,000 _ g), and the resulting plasma was stored at −70°C until measurement. The animals were randomized into two groups of experiments. First group (HC group) fed rabbit chow supplemented with 1% cholesterol, and the other group (control group) received rabbit chow only. All animals received food and water ad libitum. After one month of experiment, the blood samples were taken and stored again. The animals were euthanized by an overdose of sodium pentobarbital and ex-sanguinated. The animal's aortas were harvested for pathological investigation. Triglyceride, total cholesterol, high density lipoprotein (HDL) cholesterol and, low density lipoprotein (LDL) levels were measured using a standard enzymatic kit (Pars Azmoon Co, Iran). NOx measurement was done by total NO/nitrite/nitrate assay kit (R&D Systems, Minneapolis, USA) which based on the enzymatic conversion of nitrate to nitrite by nitrate reductase as previously described [10]. CRP (IBL Co, Germany) was measured using an enzyme-linked immunosorbent assay kit according to manufacturer’s instruction. Insulin was measured by the electrochemiluminescence immunoassay method using the Elecsys insulin reagents kit(Roche Diagnostics, Mannheim, Germany) on an automated Roche Modular Analytics Module E170 (Roche Diagnostics). The detection limit was 0.2 pmol/L.

Pathologic investigation

The entire aortas, from the aortic arch to the external iliac arteries, were fixed in buffered 10% formalin for 24 h, and then embedded in paraffin. The paraffin-embedded specimens were sectioned at 5 μm. 20 sections were stained with haematoxylin and eosin, and examined by light microscopy for the fatty streak lesions formation and the intima and media thickness of aorta measurement. Then the intima / media thickness (IMT) ratios were calculated as the atheroma formation index for each animal.

Statistical analysis

The data are reported as the mean ± SEM. A statistical software package, SPSS (version 13), was used to perform statistical analysis. The data were tested for normality and homogeneity of variance. Paired and unpaired Student's t-test was used to assess the significance of any changes within and between groups respectively. Statistical significance was accepted at p < 0.05.

Results

The cholesterol-rich diet induced a significant increase in total cholesterol, LDL-cholesterol, and HDL-cholesterol in hypercholesterolemic group while there were no significant changes of these parameters in control group. There was significant difference in total cholesterol, LDL-, and HDL between two groups of experiment (Table 1).
Table 1

The serum levels of total cholesterol, LDL, HDL, Insulin in two groups of the study at baseline and after experiment

 

P value(before and after)

After experiment

Before experiment

Total cholesterol (mg/dl)

   

Case

109.4 ± 12.04

2130.9 ± 171.8*

0.002

control

118.6 ± 12.1

138.02 ± 9.8

0.4

LDL-cholesterol(mg/dl)

   

Case

89.2 ± 8.2

1418.9 ± 164.6*

0.003

control

86.6 ± 7.6

88.7 ± 5.1

0.07

HDL-cholesterol(mg/dl)

   

Case

15.7 ± 1.4

91.7 ± 8.0*

0.019

control

13.0 ± 2.8

12.0 ± 3.4

0.6

Insulin(pmol/ml)

   

Case

0.80 ± 0.06

1.16 ± 0.07*

0.04

control

0.98 ± 0.2

0.89 ± 0.2

0.1

*Significant difference between two groups of experiment (p <0.05). Student’s t-test was used to assess the significance of the parameter changes between groups. Values are mean ± S.E.

There was no significant difference in plasma level of insulin before and after experiment in control group (p <0.05) while the insulin level was significantly increased in case group (Table 1). There was significant difference in plasma levels of insulin between two groups of experiment (p <0.05) (Table 1).

Similarly, there was no significant difference in plasma level of total NO metabolite before and after experiment in control group while the total NO metabolite level was significantly increased (p <0.05) (Figure 1). There were significantly more plasma levels of total NO metabolite in cases compare to control group (p <0.05) (Figure 1).
https://static-content.springer.com/image/art%3A10.1186%2F2251-6581-11-5/MediaObjects/40200_2012_Article_3_Fig1_HTML.jpg
Figure 1

Total nitric oxide metabolite (μmol/l) levels before and after of experiment in case and control groups. Paired and unpaired Student’s t-test was used to assess the significance of parameter changes within and between groups respectively. (P <0.05).

The plasma level of CRP significantly increased in case group (p <0.05) (Figure 2) whereas there was No significant difference in plasma level of CRP, insulin and total NO metabolite were found before and after experiment in control group (Figure 2). There was significant increased plasma levels of CRP in cases compare to control group (p <0.05) (Figure 2).
https://static-content.springer.com/image/art%3A10.1186%2F2251-6581-11-5/MediaObjects/40200_2012_Article_3_Fig2_HTML.jpg
Figure 2

C-reactive protein levels before and after of experiment in case and control groups. Paired and unpaired Student’s t-test was used to assess the significance of any changes within and between groups respectively (P <0.05).

At the end of study, there was no fatty streak lesions in the control group aortas while the IMT ratio was 0.27 ± 0.1 in HC group (p = 0.05).

There was a significant negative correlation between plasma levels of insulin and CRP concentration (r = −0.99, p = 0.03) by the end of experiment in control group.

Discussion

This study was designed to investigate the insulin alteration as a consequence of hypercholesterolemic diet in rabbit model of early atherosclerosis. The cholesterol-rich diet resulted in a significant increase in total cholesterol, LDL-cholesterol, and HDL-cholesterol as well as the development of early lesions that were representative of fatty streak initiation similar to those in humans. Thus, the model allowed us to examine some factor alteration during the initiation of atherosclerosis. In current experiment, CRP significantly increased in hypercholesterolemic rabbits while there was no significant change in control group.CRP has not only been proposed as risk factors of cardiovascular disease, but has also been associated with the variables of insulin resistance syndrome [11]. Since hypercholesterolemia is a major participator in the inflammatory process of atherosclerosis, several in vitro and in vivo studies have been showed the increased level of CRP in hypercholesterolemic animals and patients [12, 13].

As the results of our study indicated, 30 days of cholesterol-feeding enhanced the content of total nitrite, as has been demonstrated previously [1416]. It has been proposed that enhanced NO synthesis might be a defense mechanism to compensate for continuous inactivation of NO by oxygen-derived free radicals [17, 18].Another proposed mechanisms responsible for the elevation of nitrite may be NO production by other isoforms of Nitric Oxide Synthase (NOS)enzymes. Increased NOS mRNA and protein of atherosclerotic vessels reported in other experiments showing that aortas of hypercholesterolemic rabbits release larger quantities of nitrogen oxides than do normal vessels in early atherosclerosis [19].

Interestingly, in parallel to total NO metabolite alteration, the hypercholesterolemia induced insulin increment in rabbits. At the cellular level, it has been shown that exposure to insulin increases eNOS mRNA and protein synthesis [20, 21]. Furthermore, insulin increased eNOS production through increasing the activity of AP-1, a transcription factor that bind to the eNOS promoter [20].

Furthermore, in humans, infusion of insulin causes NO dependent vasodilatation and increased blood flow [22]. In both humans [23] and in animal models of insulin resistance [24], there is a specific impairment of PI3K-dependent signaling pathways. Thus, insulin resistance would be associated with a decrease in eNOS phosphorylation and decreased endothelial NO production. So, it seems that early hyperinsulinemia in the beginning of the atherosclerosis may be a protective mechanism for endothelial function. However, it has been shown that prolonged exposure of endothelial cells to high insulin levels induces a downregulation of the PI3K/Akt/eNOS axis. Such impairment of insulin signaling in prolonged hyperinsulinemia may result in ED and promote atherogenesis [25].

In this study, there was a significant negative correlation between plasma levels of insulin and CRP concentration several experiments demonstrated the anti-inflammatory effects of insulin [2630]. It has been showed that insulin suppressed the expression of the pro-inflammatory intracellular adhesion molecule (ICAM)-1, the chemokine, monocyte chemoattractant protein-1 (MCP-1), and the key pro-inflammatory transcription factor, nuclear factor [kappa]B (NF[kappa]B) in human aortic endothelial cells at physiologically relevant concentrations [26, 27]. In patients with acute myocardial infarction, insulin also suppressed C-reactive protein (CRP) and serum amyloid A (SAA) by 40% within 24 h of the start of the insulin infusion while glucose concentrations rendered unchanged [28]. This effect of insulin was corroborated in patients with myocardial infarction as well as in patients undergoing coronary artery bypass grafts in two studies [2830].

In summary, insulin may promotes endothelial function, through increased NO production, which may has anti-inflammatory effects and cause slower atherosclerotic progression.

Acknowledgement

This study was supported by Isfahan University of Medical sciences, Isfahan, Iran (Grant #386327) and physiology research center.

Declarations

Authors’ Affiliations

(1)
Physiology Research Center, Isfahan University of Medical Sciences
(2)
Water and electrolytes research center, Isfahan University of Medical Sciences

References

  1. Potenza MA, Addabbo F, Montagnani M: Vascular actions of insulin with implications for endothelial dysfunction. Am J Physiol Endocrinol Metab 2009, 297: E568-E577. 10.1152/ajpendo.00297.2009View ArticlePubMed
  2. Symons JD, McMillin SL, Riehle C, et al.: Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure. Circ Res 2009, 104: 1085–1094. 10.1161/CIRCRESAHA.108.189316PubMed CentralView ArticlePubMed
  3. Collin B, Busseuil D, Zeller M, et al.: Increased superoxide anion production is associated with early atherosclerosis and cardiovascular dysfunctions in a rabbit model. Mol Cell Biochem 2007, 294: 225–235. 10.1007/s11010-006-9263-yView ArticlePubMed
  4. Schachinger V, Zeiher AM: Atherogenesis-recent insights into basic mechanisms and their clinical impact. Nephrol Dial Transplant 2002, 17: 2055–2064. 10.1093/ndt/17.12.2055View ArticlePubMed
  5. Davignon J, Ganz P: Role of endothelial dysfunction in atherosclerosis. Circulation 2004, 109: III-27-III-32. 10.1161/01.CIR.0000131515.03336.f8View Article
  6. Akim J, Montagnani M, Koh KK, et al.: Reciprocal relationships between insulin resistance and endothelial dysfunction molecular and pathophysiological mechanisms. Circulation 2006, 113: 1888–1904. 10.1161/CIRCULATIONAHA.105.563213View Article
  7. Muniyappa R, Iantorno M, Quon MJ: An integrated view of insulin resistance and endothelial dysfunction. Endocrinol Metab Clin North Am 2008, 37: 685–711. 10.1016/j.ecl.2008.06.001PubMed CentralView ArticlePubMed
  8. Imrie H, Abbas A, Kearney M: Insulin resistance, lipotoxicity and endothelial dysfunction. Biochim Biophys Acta 2010, 1801: 320–326. 10.1016/j.bbalip.2009.09.025View ArticlePubMed
  9. Javanmard SH, Nematbakhsh M, Sanei MH: Early prevention by L-Arginine attenuates coronary atherosclerosis in a model of hypercholesterolemic animals; no positive results for treatment. Nutr Metab 2009, 6: 13. 10.1186/1743-7075-6-13View Article
  10. Saito M, Ishimitsu T, Minami J, et al.: Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis 2003, 167: 73–79. 10.1016/S0021-9150(02)00380-5View ArticlePubMed
  11. Jialal I, Devaraj S, Venugopal SK: C-reactive protein: risk marker or mediator in atherothrombosis. Hypertension 2004, 44: 6–11. 10.1161/01.HYP.0000130484.20501.dfView ArticlePubMed
  12. Baldassarre D, De Jong A, Amato M, et al.: Carotid intima-media thickness and markers of inflammation, endothelial damage and homeostasis. Ann Med 2008, 40: 21–44. 10.1080/07853890701645399View ArticlePubMed
  13. Minor RL, Myers RP, Guerra R, et al.: Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest 1990, 86: 2109–2116. 10.1172/JCI114949PubMed CentralView ArticlePubMed
  14. Nematbakhsh M, Hayat-Davoodi P, Rajabi P, et al.: The effect of estrogen on endothelial permeability of aorta and the level of serum nitrite concentration in cholesterol-fed ovariectomized rabbit. Iran Biomed J 2002, 6: 77–82.
  15. Haghjooyjavanmard S, Nematbakhsh M, Monajemi A, et al.: Von Willebrand factor, C-reactive protein, nitric oxide, and vascular endothelial growth factor in a dietary reversal model of hypercholesterolemia in rabbit. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2008, 152: 91–95.View ArticlePubMed
  16. Ferlito S, Gallina M, Catassi S, et al.: Nitrite plasma levels in normolipidemic and hypercholestrolemic patients with peripheral occlusive arteriopathy. Panminerva Med 1999, 41: 307–309.PubMed
  17. Cai H, Harrison DG: Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000, 87: 840–844. 10.1161/01.RES.87.10.840View ArticlePubMed
  18. Kanazawa K, Kawashima S, Mikami S, et al.: Endothelial constitutive nitric oxide synthase protein and mRNA increased in rabbit atherosclerotic aorta despite impaired endothelium-dependent vascular relaxation. Am J Pathol 1996, 148: 1949–1956.PubMed CentralPubMed
  19. Fisslthaler B, Benzing T, Busse R, et al.: Insulin enhances the expression of the endothelial nitric oxide synthase in native endothelial cells: a dual role for Akt and AP-1. Nitric Oxide 2003, 8: 253–261. 10.1016/S1089-8603(03)00042-9View ArticlePubMed
  20. Kuboki K, Jiang ZY, Takahara N, et al.: Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 2000, 101: 676–681. 10.1161/01.CIR.101.6.676View ArticlePubMed
  21. Baron AD: Insulin and the vasculature–old actors, new roles. J Investig Med 1996, 44: 406–412.PubMed
  22. Cusi K, Maezono K, Osman A, et al.: Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000, 105: 311–320. 10.1172/JCI7535PubMed CentralView ArticlePubMed
  23. Jiang ZY, Lin YW, Clemont A: Insulin inhibits NFkappaB and MCP-1 expression in human aortic endothelial cells Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest 1999, 104: 447–457. 10.1172/JCI5971PubMed CentralView ArticlePubMed
  24. Madonna R, De Caterina R: Prolonged exposure to high insulin impairs the endothelial PI3-kinase/Akt/nitric oxide signaling. Thrombi Headmost 2009, 101: 345–350.
  25. Aljada A, Dandona P: Effect of insulin on human aortic endothelial nitric oxide synthase. Metabolism 2000, 49: 147–150. 10.1016/S0026-0495(00)91039-4View ArticlePubMed
  26. Aljada A, Ghanim H, Saadeh R, et al.: Insulin inhibits NFkappaB and MCP-1 expression in human aortic endothelial cells. J Clin Endocrinol Metab 2001, 86: 450–453. 10.1210/jc.86.1.450PubMed
  27. Chaudhuri A, Janicke D, Wilson MF: Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 2004, 109: 849–854. 10.1161/01.CIR.0000116762.77804.FCView ArticlePubMed
  28. Koskenkari JK, Kaukoranta PK, Rimpilainen J: Anti-inflammatory effect of high-dose insulin treatment after urgent coronary revascularization surgery. Acta Anaesthesiol Scand 2006, 50: 962–969. 10.1111/j.1399-6576.2006.01100.xView ArticlePubMed
  29. Ji L, Fu F, Zhang L, et al.: Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/nitrative stress. Am J Physiol Endocrinol Metab 2010, 298: E871-E880. 10.1152/ajpendo.00623.2009View ArticlePubMed
  30. Kim JA, Montagnani M, Koh KK, Quon MJ: Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006, 113: 1888–1904. 10.1161/CIRCULATIONAHA.105.563213View ArticlePubMed

Copyright

© Javanmard et al.; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement